Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 2,397

Maltese among group of scientists who have discovered new therapies to combat cancer

A Maltese scientist working with a group of researchers have found a way to re-activate the human immune system to fight cancer cells that can develop.

Dr. David Saliba is optimistic that their research will pave the way for the development of new therapies to fight cancer.

Together with a group of researchers from the University of Malta and the University of Oxford, Dr. David Saliba has for the last four years researched about how immune system cells communicate with each other, especially when it comes to combating cancer.

Is Treating Cancer with Odors the Future of Cancer Therapy?

Every time you inhale through your nose, olfactory receptors in your nasal passages enable your sense of smell to function. These receptors consist of protein complexes that help you detect chemicals floating in the air.

But research now shows that those types of receptors aren’t only found along your breathing passages. They’re all over the body in a wide variety of organs, and they influence what organs like your liver and intestines are doing.

Added to that, cancer cells possess their own collection of olfactory receptors that affect how they function. And those receptors, some researchers believe, might represent one of cancer’s vulnerabilities – and a key to destroying cancers with scents.

Rotavirus vaccine: A potential new role as an anticancer agent

Very interesting.

Numerous vaccines, from flu shots to those those that help thwart chickenpox and measles, are widely used to guard against contagion, but researchers in France are proposing a breakthrough role for rotavirus vaccines: deploying them in cancer treatment.

Scientists from throughout France—Paris, Lyon, Villejuif and beyond—are part of a large research team that has asked a tantalizing question: Can rotavirus vaccines be repurposed to overcome resistance in cancer immunotherapy? The team is focusing on resistance that emerges to the form of known as checkpoint blockade immunotherapy.

So far, their investigation suggests the question about repurposing can be answered with a resounding “yes.”

Discovery may help derail Parkinson’s ‘runaway train’

Researchers at the University of Dundee have made a discovery they believe has the potential to put the brakes on the ‘runaway train’ that is Parkinson’s disease.

The team, based at the Medical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) in the School of Life Sciences, have discovered a new enzyme that inhibits the LRRK2 . Mutations of the LRRK2 gene are the most common cause of genetic Parkinson’s.

Enzymes are molecular machines that regulate the required to maintain healthy functioning life. They can also be targeted by drugs to increase or decrease the level of certain activity –in this instance the LRRK2 pathway.

Portland teen’s cancer detection project wins national prize; rural district wants 2020 bond, won’t say what it’s for: The week in education

A Portland teen won second place in a national technology contest, taking home $2,500 that he can use to attend science camp next summer.

Rishab Jain, 14, is a freshman at Westview High School. His winning project, which he calls the Pancreas Detective, is an artificial intelligence tool that can help diagnose pancreatic cancer through gene sequencing. The algorithm helps doctors focus on the organ during examinations, which is often obscured because it moves around the abdominal area as patients breathe and other bodily functions shift other organs as well.

Last year, the same project netted $25,000 from 3M when he attended Stoller Middle School. He used that money to fund his nonprofit, Samyak Science Society, which promotes science, technology, engineering and math education for other children, Time Magazine reported.

Science author digs into the story about a revolutionary cancer treatment used in immunotherapy

Unlike chemotherapy or radiation, which attack cancer directly, CAR-T engineers patients’ immune cells so they can do it themselves. T-cells are removed from the blood and given new genes that produce receptors that let the T-cells recognize and bind to leukemia cells with a specific protein, CD19.

The genetically modified T-cells are then multiplied in the lab and infused back into the patient, where they ideally multiply even further and begin to target and kill cancer cells with CD19.

Living skin can now be 3D-printed with blood vessels included

Researchers at Rensselaer Polytechnic Institute have developed a way to 3D print living skin, complete with blood vessels. The advancement, published online today in Tissue Engineering Part A, is a significant step toward creating grafts that are more like the skin our bodies produce naturally.

“Right now, whatever is available as a clinical product is more like a fancy Band-Aid,” said Pankaj Karande, an associate professor of chemical and and member of the Center for Biotechnology and Interdisciplinary Studies (CBIS), who led this research at Rensselaer. “It provides some accelerated wound healing, but eventually it just falls off; it never really integrates with the host .”

A significant barrier to that integration has been the absence of a functioning vascular system in the .

/* */